Lymphadenectomy for thyroid and lymph node carcinomas;Lymphadenektomie beim schilddrüsen- und nebenschilddrüsenkarzinom

Chirurg

Volumn 78, Issue 3, 2007, Pages 182-193

  Gimm, O ^a   Dralle, H ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Lymph node dissection; Nerve monitoring; Parathyroid carcinoma; Thyroid carcinoma

Indexed keywords

ADENOCARCINOMA; ADULT; CANCER STAGING; CARCINOMA; CHILD; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MEDULLARY CARCINOMA; METHODOLOGY; PAPILLARY CARCINOMA; PARATHYROID TUMOR; PARATHYROIDECTOMY; PATHOLOGY; PROGNOSIS; REVIEW; THYROID TUMOR; THYROIDECTOMY;

ADENOCARCINOMA, FOLLICULAR; ADENOCARCINOMA, PAPILLARY; ADULT; CARCINOMA; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; CHILD; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM STAGING; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; PROGNOSIS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 33947504697     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-007-1303-y     Document Type: Review

References (43)

1. Cheah WK, Arici C, Ituarte PH et al. (2002) Complications of neck dissection for thyroid cancer. World J Surg 26: 1013-1016. Epub 2002 Jun 1016
2. Chow SM, Law SC, Au SK et al. (2002) Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute. Head Neck 24: 670-677
3. Cordeiro AC, Montenegro FL, Kulcsar MA et al. (1998) Parathyroid carcinoma. Am J Surg 175: 52-55
4. Dralle H, Damm I, Scheumann GF et al. (1992) Frequency and significance of cervicomediastinal lymph node metastases in medullary thyroid carcinoma: results of a compartment-oriented microdissection method. Henry Ford Hosp Med J 40: 264-267
5. Dralle H, Damm I, Scheumann GF et al. (1994) Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today 24: 112-121
6. Dralle H, Gimm O (1996) Lymphadenektomie beim Schilddrüsencarcinom. Chirurg 67: 788-806
7. Dralle H, Sekulla C, Haerting J et al. (2004) Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery 136: 1310-1322
8. Ferlito A, Pellitteri PK, Robbins KT et al. (2002) Management of the neck in cancer of the major salivary glands, thyroid and parathyroid glands. Acta Otolaryngol 122: 673-678
9. Filho JG, Kowalski LP (2004) Postoperative complications of thyroidectomy for differentiated thyroid carcinoma. Am J Otolaryngol 25: 225-230
10. Gimm O, Dralle H (1997) Reoperation in metastasizing medullary thyroid carcinoma: is a tumor stageoriented approach justified? Surgery 122: 1124-1130; discussion 1130-1121
11. Gimm O, Lorenz K, Nguyen Thanh P et al. (2006) Das familiäre Nebenschilddrüsenkarzinom. Chirurg 77: 15-24
12. Gimm O, Rath FW, Dralle H (1998) Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg 85: 252-254
13. Gimm O, Ukkat J, Dralle H (1998) Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma. World J Surg 22: 562-567; discussion 567-568
14. Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1999) Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 86: 538-544
15. Kirkby-Bott J, Lewis P, Harmer CL, Smellie WJ (2005) One stage treatment of parathyroid cancer. Eur J Surg Oncol 31: 78-83
16. Lang BH, Lo CY, Chan WF et al. (2006) Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome. World J Surg 30: 752-758
17. Liu J, Singh B, Tallini G et al. (2006) Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer 107: 1255-1264
18. Machens A, Gimm O, Ukkat J et al. (2000) Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis. Cancer 88: 1909-1915
19. Machens A, Holzhausen HJ, Dralle H (2004) Prediction of mediastinal lymph node metastasis in medullary thyroid carcinoma. Br J Surg 91: 709-712
20. Machens A, Holzhausen HJ, Dralle H (2004) Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg 139: 43-45
21. Machens A, Holzhausen HJ, Dralle H (2005) The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer 103: 2269-2273
22. Machens A, Holzhausen HJ, Dralle H (2006) Contralateral cervical and mediastinal lymph node metastasis in medullary thyroid cancer: systemic disease? Surgery 139: 28-32
23. Machens A, Schneyer U, Holzhausen HJ, Dralle H (2005) Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. J Clin Endocrinol Metab 90: 2029-2034; Epub 2005 Jan 2025
24. Mueller-Gaertner HW, Brzac HT, Rehpenning W (1991) Prognostic indices for tumor relapse and tumor mortality in follicular thyroid carcinoma. Cancer 67: 1903-1911
25. Noguchi S, Murakami N (1987) The value of lymphnode dissection in patients with differentiated thyroid cancer. Surg Clin North Am 67: 251-261
26. Obara T, Fujimoto Y (1991) Diagnosis and treatment of patients with parathyroid carcinoma: an update and review. World J Surg 15: 738-744
27. Peixoto Callejo I, Americo Brito J, Zagalo CM, Rosa Santos J (2006) Medullary thyroid carcinoma: multivariate analysis of prognostic factors influencing survival. Clin Transl Oncol 8: 435-443
28. Podnos YD, Smith D, Wagman LD, Ellenhorn JD (2005) The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg 71: 731-734
29. Robbins KT, Medina JE, Wolfe GT et al. (1991) Standardizing neck dissection terminology. Official report of the Academy's Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg 117: 601-605
30. Schelfhout LJ, Creutzberg CL, Hamming JF et al. (1988) Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor. Eur J Cancer Clin Oncol 24: 331-337
31. Scheumann GF, Gimm O, Wegener G et al. (1994) Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18: 559-567; discussion 567-568
32. Simpson WJ, McKinney SE, Carruthers JS et al. (1987) Papillary and follicular thyroid cancer. Prognostic factors in 1,578 patients. Am J Med 83: 479-488
33. Tamagnini P, Iacobone M, Sebag F et al. (2005) Lymph node involvement in macroscopic medullary thyroid carcinoma. Br J Surg 92: 449-453
34. Tillmann (Hrsg) (2005) Atlas der Anatomie. Springer, Heidelberg
35. Timmermann W, Hamelmann WH, Thomusch O et al. (2004) Zuverlässigkeit und Konsequenzen des intraoperativen Neuromonitorings in der Schilddrüsenchirurgie. Chirurg 75: 916-922
36. van Heerden JA, Grant CS, Gharib H et al. (1990) Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 212: 395-400; discussion 400-391
37. Wittekind C, Kimpfinger M, Sobin LH (Hrsg) (2005) TNM-Atlas. 5. Aufl. Springer, Heidelberg
38. Wittekind C, Meyer HJ, Bootz F (Hrsg) (2002) TNM. Klassifkation maligner Tumoren. 6. Aufl. Springer, Berlin Heidelberg New York
39. Machens A, Hinze R, Thomusch O, Dralle H (2002) Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26: 22-28
40. Wada N, Duh QY, Sugino K et al. (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237: 399-407
41. Fleming JB, Lee JE, Bouvet M et al. (1999) Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg 230: 697-707
42. Moley J, DeBenedetti MK (1999) Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 229: 880-887
43. Scollo C, Baudin E, Travagli JP et al. (2003) Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 88: 2070-2075